Towards molecular diagnostics of invasive fungal infections

References

• Cornely OA. Aspergillus to Zygomycetes: causes, risk factors, prevention, and treatment of invasive fungal infections. Infection36(4), 296–313 (2008).
   PubMed Web of Science ®Google Scholar
• Donowitz GR, Maki DG, Crnich CJ, Pappas PG, Rolston KV. Infections in the neutropenic patient – new views of an old problem. Hematology Am. Soc. Hematol. Educ. Program113–139 (2001).
   PubMedGoogle Scholar
• Nucci M, Spector N, Bueno AP et al. Risk factors and attributable mortality associated with superinfections in neutropenic patients with cancer. Clin. Infect. Dis.24(4), 575–579 (1997).
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Anaissie EJ, Denning DW et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin. Infect. Dis.46(3), 327–360 (2008).
   PubMed Web of Science ®Google Scholar
• Richardson M, Lass-Florl C. Changing epidemiology of systemic fungal infections. Clin. Microbiol. Infect.14(Suppl. 4), 5–24 (2008).
   PubMed Web of Science ®Google Scholar
• Caston-Osorio JJ, Rivero A, Torre-Cisneros J. Epidemiology of invasive fungal infection. Int. J. Antimicrob. Agents32(Suppl. 2), S103–S109 (2008).
   PubMed Web of Science ®Google Scholar
• Lass-Florl C. The changing face of epidemiology of invasive fungal disease in Europe. Mycoses52(3), 197–205 (2009).
   PubMed Web of Science ®Google Scholar
• Marr KA, Patterson T, Denning D. Aspergillosis. Pathogenesis, clinical manifestations, and therapy. Infect. Dis. Clin. North Am.16(4), 875–894, vi (2002).
   PubMed Web of Science ®Google Scholar
• Kontoyiannis DP, Lionakis MS, Lewis RE et al. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case–control observational study of 27 recent cases. J. Infect. Dis.191(8), 1350–1360 (2005).
   PubMed Web of Science ®Google Scholar
• Hope WW, Walsh TJ, Denning DW. Laboratory diagnosis of invasive aspergillosis. Lancet Infect. Dis.5(10), 609–622 (2005).
   PubMed Web of Science ®Google Scholar
• Pasqualotto AC, Denning DW. Diagnosis of invasive fungal infections – current limitations of classical and new diagnostic methods. Busin. Brief.: Eur. Oncol. Rev. 2005 (2005).
   Google Scholar
• Ascioglu S, Rex JH, de Pauw B et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin. Infect. Dis.34(1), 7–14 (2002).
   PubMed Web of Science ®Google Scholar
• Ellepola AN, Morrison CJ. Laboratory diagnosis of invasive candidiasis. J. Microbiol (Seoul, Korea),43(Spec. No), 65–84 (2005).
   PubMed Web of Science ®Google Scholar
• Simoneau E, Kelly M, Labbe AC, Roy J, Laverdiere M. What is the clinical significance of positive blood cultures with Aspergillus sp in hematopoietic stem cell transplant recipients? A 23 year experience. Bone Marrow Transplant.35(3), 303–306 (2005).
   PubMed Web of Science ®Google Scholar
• Barnes RA. Early diagnosis of fungal infection in immunocompromised patients. J. Antimicrob. Chemother.61(Suppl. 1), i3–i6 (2008).
   PubMed Web of Science ®Google Scholar
• Leeflang MM, Debets-Ossenkopp YJ, Visser CE et al. Galactomannan detection for invasive aspergillosis in immunocompromized patients. Cochrane Database Syst. Rev.(4), CD007394 (2008).
   Google Scholar
• Adam O, Auperin A, Wilquin F et al. Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies. Clin. Infect. Dis.38(6), 917–920 (2004).
   PubMed Web of Science ®Google Scholar
• Zandijk E, Mewis A, Magerman K, Cartuyvels R. False-positive results by the platelia Aspergillus galactomannan antigen test for patients treated with amoxicillin-clavulanate. Clin. Vaccine Immunol.15(7), 1132–1133 (2008).
   PubMedGoogle Scholar
• Racil Z, Kocmanova I, Lengerova M, Winterova J, Mayer J. Intravenous PLASMA-LYTE as a major cause of false-positive results of platelia Aspergillus test for galactomannan detection in serum. J. Clin. Microbiol.45(9), 3141–3142 (2007).
   PubMed Web of Science ®Google Scholar
• Wheat LJ, Walsh TJ. Diagnosis of invasive aspergillosis by galactomannan antigenemia detection using an enzyme immunoassay. Eur. J. Clin. Microbiol. Infect. Dis.27(4), 245–251 (2008).
   PubMed Web of Science ®Google Scholar
• Steinbach WJ, Addison RM, McLaughlin L et al. Prospective Aspergillus galactomannan antigen testing in pediatric hematopoietic stem cell transplant recipients. Pediatr. Infect. Dis. J.26(7), 558–564 (2007).
   PubMed Web of Science ®Google Scholar
• Marty FM, Koo S. Role of (1-->3)-β-D-glucan in the diagnosis of invasive aspergillosis. Med. Mycol.1–8 (2008).
   Web of Science ®Google Scholar
• Pickering JW, Sant HW, Bowles CA, Roberts WL, Woods GL. Evaluation of a (1-->3)-β-D-glucan assay for diagnosis of invasive fungal infections. J. Clin. Microbiol.43(12), 5957–5962 (2005).
   PubMed Web of Science ®Google Scholar
• Persat F, Ranque S, Derouin F et al. Contribution of the (1-->3)-β-D-glucan assay for diagnosis of invasive fungal infections. J. Clin. Microbiol.46(3), 1009–1013 (2008).
   PubMed Web of Science ®Google Scholar
• De Pauw B, Walsh TJ, Donnelly JP et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin. Infect. Dis.46(12), 1813–1821 (2008).
   PubMed Web of Science ®Google Scholar
• Raad I, Hanna H, Sumoza D, Albitar M. Polymerase chain reaction on blood for the diagnosis of invasive pulmonary aspergillosis in cancer patients. Cancer94(4), 1032–1036 (2002).
   PubMed Web of Science ®Google Scholar
• El-Mahallawy HA, Shaker HH, Ali Helmy H, Mostafa T, Razak Abo-Sedah A. Evaluation of pan-fungal PCR assay and Aspergillus antigen detection in the diagnosis of invasive fungal infections in high risk paediatric cancer patients. Med. Mycol.44(8), 733–739 (2006).
   PubMed Web of Science ®Google Scholar
• Lau A, Chen S, Sorrell T et al. Development and clinical application of a panfungal PCR assay to detect and identify fungal DNA in tissue specimens. J. Clin. Microbiol.45(2), 380–385 (2007).
   PubMed Web of Science ®Google Scholar
• Loffler J, Hebart H, Sepe S et al. Detection of PCR-amplified fungal DNA by using a PCR-ELISA system. Med. Mycol.36(5), 275–279 (1998).
   PubMed Web of Science ®Google Scholar
• Lass-Florl C, Gunsilius E, Gastl G et al. Diagnosing invasive aspergillosis during antifungal therapy by PCR analysis of blood samples. J. Clin. Microbiol.42(9), 4154–4157 (2004).
   PubMed Web of Science ®Google Scholar
• Florent M, Katsahian S, Vekhoff A et al. Prospective evaluation of a polymerase chain reaction-ELISA targeted to Aspergillus fumigatus and Aspergillus flavus for the early diagnosis of invasive aspergillosis in patients with hematological malignancies. J. Infect. Dis.193(5), 741–747 (2006).
   PubMed Web of Science ®Google Scholar
• Loeffler J, Henke N, Hebart H et al. Quantification of fungal DNA by using fluorescence resonance energy transfer and the light cycler system. J. Clin. Microbiol.38(2), 586–590 (2000).
   PubMed Web of Science ®Google Scholar
• White PL, Linton CJ, Perry MD, Johnson EM, Barnes RA. The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting. Clin. Infect. Dis.42(4), 479–486 (2006).
   PubMed Web of Science ®Google Scholar
• Baskova L, Landlinger C, Preuner S, Lion T. The Pan-AC assay: a single-reaction real-time PCR test for quantitative detection of a broad range of Aspergillus and Candida species. J. Med. Microbiol.56(Pt 9), 1167–1173 (2007).
   PubMed Web of Science ®Google Scholar
• Klingspor L, Jalal S. Molecular detection and identification of Candida and Aspergillus spp. from clinical samples using real-time PCR. Clin. Microbiol. Infect.12(8), 745–753 (2006).
   PubMed Web of Science ®Google Scholar
• Vollmer T, Stormer M, Kleesiek K, Dreier J. Evaluation of novel broad-range real-time PCR assay for rapid detection of human pathogenic fungi in various clinical specimens. J. Clin. Microbiol.46(6), 1919–1926 (2008).
   PubMed Web of Science ®Google Scholar
• Schabereiter-Gurtner C, Selitsch B, Rotter ML, Hirschl AM, Willinger B. Development of novel real-time PCR assays for detection and differentiation of eleven medically important Aspergillus and Candida species in clinical specimens. J. Clin. Microbiol.45(3), 906–914 (2007).
   PubMed Web of Science ®Google Scholar
• Skladny H, Buchheidt D, Baust C et al. Specific detection of Aspergillus species in blood and bronchoalveolar lavage samples of immunocompromised patients by two-step PCR. J. Clin. Microbiol.37(12), 3865–3871 (1999).
   PubMed Web of Science ®Google Scholar
• Williamson EC, Leeming JP, Palmer HM et al. Diagnosis of invasive aspergillosis in bone marrow transplant recipients by polymerase chain reaction. Br. J. Haematol.108(1), 132–139 (2000).
   PubMed Web of Science ®Google Scholar
• Halliday C, Hoile R, Sorrell T et al. Role of prospective screening of blood for invasive aspergillosis by polymerase chain reaction in febrile neutropenic recipients of haematopoietic stem cell transplants and patients with acute leukaemia. Br. J. Haematol.132(4), 478–486 (2006).
   PubMed Web of Science ®Google Scholar
• Leinberger DM, Schumacher U, Autenrieth IB, Bachmann TT. Development of a DNA microarray for detection and identification of fungal pathogens involved in invasive mycoses. J. Clin. Microbiol.43(10), 4943–4953 (2005).
   PubMed Web of Science ®Google Scholar
• Spiess B, Seifarth W, Hummel M et al. DNA microarray-based detection and identification of fungal pathogens in clinical samples from neutropenic patients. J. Clin. Microbiol.45(11), 3743–3753 (2007).
   PubMed Web of Science ®Google Scholar
• Loeffler J, Dorn C, Hebart H et al. Development and evaluation of the nuclisens basic kit NASBA for the detection of RNA from Candida species frequently resistant to antifungal drugs. Diagn. Microbiol. Infect. Dis.45(3), 217–220 (2003).
   PubMed Web of Science ®Google Scholar
• Landlinger C, Baskova L, Preuner S et al. Identification of fungal species by fragment length analysis of the internally transcribed spacer 2 region. Eur. J. Clin. Microbiol. Infect. Dis.28(6), 613–622 (2008).
   PubMed Web of Science ®Google Scholar
• Leaw SN, Chang HC, Sun HF et al. Identification of medically important yeast species by sequence analysis of the internal transcribed spacer regions. J. Clin. Microbiol.44(3), 693–699 (2006).
   PubMed Web of Science ®Google Scholar
• Diaz MR, Fell JW. High-throughput detection of pathogenic yeasts of the genus trichosporon. J. Clin. Microbiol.42(8), 3696–3706 (2004).
   PubMed Web of Science ®Google Scholar
• Das S, Brown TM, Kellar KL, Holloway BP, Morrison CJ. DNA probes for the rapid identification of medically important Candida species using a multianalyte profiling system. FEMS Immunol. Med. Microbiol.46(2), 244–250 (2006).
   PubMedGoogle Scholar
• Landlinger C, Preuner S, Willinger B et al. Species-specific identification of a wide range of clinically relevant fungal pathogens by the Luminex xMAPTM technology. J. Clin. Microbiol. DOI: 10.1128/JCM.01558-08 (2009) (Epub ahead of print).
   PubMedGoogle Scholar
• Gharizadeh B, Norberg E, Loffler J et al. Identification of medically important fungi by the pyrosequencing technology. Mycoses47(1–2), 29–33 (2004).
   PubMed Web of Science ®Google Scholar
• Montero CI, Shea YR, Jones PA et al. Evaluation of pyrosequencing technology for the identification of clinically relevant non-dematiaceous yeasts and related species. Eur. J. Clin. Microbiol. Infect. Dis.27(9), 821–830 (2008).
   PubMed Web of Science ®Google Scholar
• Landlinger C, Baskova L, Preuner S et al. Rapid detection of invasive fungal infections in hemato-oncological patients. Blood (ASH Annual Meeting Abstracts)112, 1468(2008).
   Google Scholar
• Loeffler J, Hebart H, Brauchle U, Schumacher U, Einsele H. Comparison between plasma and whole blood specimens for detection of Aspergillus DNA by PCR. J. Clin. Microbiol.38(10), 3830–3833 (2000).
   PubMed Web of Science ®Google Scholar
• Metwally L, Fairley DJ, Coyle PV et al. Comparison of serum and whole-blood specimens for the detection of Candida DNA in critically ill, non-neutropenic patients. J. Med. Microbiol.57(Pt 10), 1269–1272 (2008).
   PubMed Web of Science ®Google Scholar
• Mengoli C, Cruciani M, Barnes RA, Loeffler J, Donnelly JP. Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis. Lancet Infect. Dis.9(2), 89–96 (2009).
   PubMed Web of Science ®Google Scholar
• White PL, Barton R, Guiver M et al. A consensus on fungal polymerase chain reaction diagnosis?: a United Kingdom–Ireland evaluation of polymerase chain reaction methods for detection of systemic fungal infections. J. Mol. Diagn.8(3), 376–384 (2006).
   PubMed Web of Science ®Google Scholar